Wall Street Numbers logo
Wall Street Numbers logo
Wall Street Numbers
Kiniksa Pharmaceuticals International, plc company logo
Kiniksa Pharmaceuticals International, plc logo

Kiniksa Pharmaceuticals International, plc (KNSA)

Profile

Company profile for Kiniksa Pharmaceuticals International, plc (KNSA)
MetricValue
Full NameKiniksa Pharmaceuticals International, plc
TickerNASDAQ: KNSA
ExchangeNASDAQ
SectorHealthcare
IndustrySpecialty & Generic Drug Manufacturers
CountryUnited Kingdom
IPO
IndexesNot included
Websitekiniksa.com
Employees315

Key Metrics

Kiniksa Pharmaceuticals International, plc Key Details
MetricDateValue
Price$40.58
Price, 1D Change-3.39%
Market Cap$3B
-
PE Ratio90.52
Beta0.51
Revenue$423M
Revenue, 1Y Change+56.60%
EPS-$0.60
EPS, 1Y Change-408.84%

Chart

Add series to chart(max: 6)
Series
SUGGESTED SERIES
Kiniksa Pharmaceuticals International, plc chart

Events

Kiniksa Pharmaceuticals International, plc Events
MetricDateValue
Next Earnings
Last Qtr. Earnings
Last Ann. Earnings
Last Ex-DividendN/AN/A
Next Ex-DividendN/AN/A
Last SplitN/AN/A
Next SplitN/AN/A
Last Ticker ChangeN/AN/A
Next Ticker ChangeN/AN/A

🔒 Log In To Unlock Full Data

Estimates

KNSA Estimates
MetricDateValue
EPS-$0.60
EPS Estimate$1.19
EPS Est. Change+296.10%
Revenue$423.24M
Revenue Estimate$670.54M
Revenue Est. Change+58.43%
Current Price$40.58
Price Target-$55.00
Price Tgt. Change-+35.53%

🔒 Log In To Unlock Full Data

EPS

KNSA EPS reported versus estimate values
YearEstimateReportedSurprise / Exp.
-$0.30$0.20+165.27%
-$0.21-$0.60-183.50%
$1.19N/A+296.10%
$1.84N/A+404.60%
KNSA EPS reported versus estimate values chart

Revenue

KNSA revenue reported versus estimate values chart
YearEstimateReportedSurprise / Exp.
$256.74M$270.26M+5.27%
$424.18M$423.24M-0.22%
$670.54MN/A+58.43%
$870.47MN/A+105.67%
KNSA revenue reported versus estimate values chart

🔒 Log In To Unlock Full Data

Performance

KNSA Performance
MetricDateValue
Price, 1Y+99.80%
Price, 3Y+163.34%
Market Cap, 1Y+108.84%
Market Cap, 3Y+186.38%
Revenue, 1Y+56.60%
Revenue, 3Y+998.07%
EPS, 1Y-408.84%
EPS, 3Y+73.74%

🔒 Log In To Unlock Full Data

Technical Indicators

KNSA Technical Indicators
MetricDateValue
Current Price$40.58
SMA 200$32.38
SMA 200 vs Price-20.22%
SMA 50$40.70
SMA 50 vs Price+0.29%
Beta0.51
ATR$1.37
14-Day RSI54.29
10-Day Volatility27.03%
1-Year Volatility43.77%

Dividends

KNSA Dividends
MetricDateValue
N/A-
UpcomingN/AN/A
-
-
Dividends Paid$0.00
Payout Ratio0.00%

🔒 Log In To Unlock Full Data

Income & Profitability

KNSA Income & Profitability
MetricDateValue
Revenue$423.24M
EPS-$0.60
Gross Profit$233.57M
Gross Margin55.19%
Operating Profit-$45.62M
Operating Margin-10.78%
Net Income-$43.19M
Net Margin-10.21%
EBITDA-$43.92M

🔒 Log In To Unlock Full Data

Financial Health

KNSA Financial Health
MetricDateValue
Debt To Equity0.02
Current Ratio3.30
Quick Ratio3.04
-
F-Score7
Altman Z-Score12.68

Valuations

KNSA Valuations
MetricDateValue
PE Ratio90.52
PS Ratio5.14
PB Ratio5.75
EV/EBITDA68.95
Enterprise ValueN/A-

Balance Sheet

KNSA Balance Sheet
MetricDateValue
Book Value$438.44M
Cash & Equivalents$183.58M
Total Assets$580.55M
Current Assets$331.80M
Total Liabilities$142.12M
Current Liabilities$100.62M
Total Debt$9.86M
Short Term Debt$1.99M
Accounts Payable$2.04M

Expenses

KNSA Expenses
MetricDateValue
Total Expenses$468.86M
Operating Expenses$407.95M
Cost Of Goods Sold$189.67M
SG&A$168.01M
D&A$1.70M
Interest Expense$0.00
Income Tax$7.04M

Cash Flow

KNSA Cash Flow
MetricDateValue
CFO$25.69M
CFI$37.67M
CFF$12.27M
Capex$277.00K
Free Cash Flow$25.41M

Recent analyst updates

KNSA Recent analyst updates
MetricDateValue
Goldman Sachs→
Citigroup→
Wedbush→
TD Cowen
Wells Fargo→
Jefferies→
Wells Fargo→
Jefferies→
Wedbush→
Citigroup

Analyst sentiment

Sentiment over the past month
KNSA analyst sentiment distribution chart

Institutional ownership

Largest institutional holders by ownership percentage
KNSA institutional ownership distribution chart

Screeners with KNSA

Data Sources & References

  1. KNSA Official Website www.kiniksa.com
  2. Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1730430/000110465925103180/0001104659-25-103180-index.htm
  3. Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1730430/000155837025001505/0001558370-25-001505-index.htm
  4. KNSA Profile on Yahoo Finance finance.yahoo.com/quote/KNSA
  5. KNSA Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/knsa

FAQ

  • What is the ticker symbol for Kiniksa Pharmaceuticals International, plc?

    The ticker symbol for Kiniksa Pharmaceuticals International, plc is NASDAQ:KNSA

  • Does Kiniksa Pharmaceuticals International, plc pay dividends?

    No, Kiniksa Pharmaceuticals International, plc does not pay dividends

  • What sector is Kiniksa Pharmaceuticals International, plc in?

    Kiniksa Pharmaceuticals International, plc is in the Healthcare sector

  • What industry is Kiniksa Pharmaceuticals International, plc in?

    Kiniksa Pharmaceuticals International, plc is in the Specialty & Generic Drug Manufacturers industry

  • What country is Kiniksa Pharmaceuticals International, plc based in?

    Kiniksa Pharmaceuticals International, plc is headquartered in United Kingdom

  • When did Kiniksa Pharmaceuticals International, plc go public?

    Kiniksa Pharmaceuticals International, plc initial public offering (IPO) was on May 25, 2018

  • Is Kiniksa Pharmaceuticals International, plc in the S&P 500?

    No, Kiniksa Pharmaceuticals International, plc is not included in the S&P 500 index

  • Is Kiniksa Pharmaceuticals International, plc in the NASDAQ 100?

    No, Kiniksa Pharmaceuticals International, plc is not included in the NASDAQ 100 index

  • Is Kiniksa Pharmaceuticals International, plc in the Dow Jones?

    No, Kiniksa Pharmaceuticals International, plc is not included in the Dow Jones index

  • When was Kiniksa Pharmaceuticals International, plc last earnings report?

    Kiniksa Pharmaceuticals International, plc's most recent earnings report was on October 28, 2025

  • When does Kiniksa Pharmaceuticals International, plc report earnings?

    The next expected earnings date for Kiniksa Pharmaceuticals International, plc is March 3, 2026